Skip to content
No picture yet

Aa-Feno-Super 160 mg – DIN 02246860

Aa-Feno-Super is Fenofibrate 160 mg (tablet), sold in Canada. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Aa Pharma Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Fenofibrate 160 mg

Brand
Aa-Feno-Super
Strength
160 mg
Used for
High cholesterol, high triglycerides and heart disease
Form
Tablet
Manufacturer
Aa Pharma Inc
Drug class
Peroxisome proliferator-activated receptor alpha agonist
Sold in
Canada
DIN
02246860

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Fenofibrate pills and guides

What is Fenofibrate used for?

Fenofibrate is used for high cholesterol, high triglycerides and heart disease.

Medicine type
Peroxisome proliferator-activated receptor alpha agonist
Official uses from the US prescribing label

Primary Hypercholesterolemia or Mixed Dyslipidemia

Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Severe Hypertriglyceridemia

Fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention.

Markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied.

Important Limitations of Use

Fenofibrate at a dose equivalent to 160 mg of fenofibrate tablet was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02246860.
  • It names Aa-Feno-Super, Fenofibrate 160 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Aa-Feno-Super by Aa Pharma Inc.

In Canada: prescription only.

Ingredients

Active: Fenofibrate

Other Fenofibrate pills